Presentations 2023
Presentations made by UNC Neurology faculty and residents in 2023 include the following:
Jessica Werdel, NP, gave the oral abstract presentation: “Choosing Wisely: A QI Initiative to Reduce Daily Labs in the Neuroscience ICU” on January 22nd, 2023, at the Society of Critical Care Medicine Critical Care Congress, San Francisco, California. Her research was conducted as a participant in Duke Johnson & Johnson Nurse Leadership Program. Her abstract was co-authored by co-authored by Binta Diallo, Rhonda Cadena, Grace Dehoff, Winnie Lau, Clio Rubinos, Matthew Sharrock, and Casey Olm-Shipman.
James F. Howard, Jr., M.D., FAAN
Howard JF Jr, Complement Therapeutics in Myasthenia Gravis (by webcast), 26th Saudi Neurological Society in association with the 18th Pan Arab Union & 13th Gulf Neurology Meeting Symposia, Jeddah, Kingdom of Saudi Arabia, January 12, 2023.
Howard JF Jr, US Perspective: Myasthenia Gravis Management in the New Era of Biologics (by webcast), at the International MG Forum, China, January 14, 2023.
Poster “Neuromyelitis Optica Spectrum Disorder in a Pediatric Patient with ARCN1-related syndrome” authored by Dr. Fazila Aseem and mentored by Dr. Irena Dujmovic Basuroski was presented at the 2023 NC Neurological Society Annual Meeting (Pinehurst, NC; Feb. 10-12, 2023) and was awarded the 2nd best poster award at this meeting.
PGY 2 Resident Amanda Crooks and PGY 4 Resident Lindsey Krawchuk both taught at the UNC School of Medicine, Transition to Residency Program
PGY3 Resident Joshua Nardin had a platform presentation at North Carolina Neurologic Society Meeting in February titled “Complement Inhibition for gMG; Recent Developments in Therapeutic Options”.
PGY 3 Resident Diana Ontiveros completed the Academy of Educators Teaching as Residents Program
Clio Rubinos, MD, MSCR
Speaker “From the Beginning: Updates and Future Direction in Understanding Autoregulation in Coma and Disorders of Consciousness” at the International Stroke Conference, Dallas, Texas – USA. February 9th, 2023.
Speaker “Debate: Hypertonic Saline for ICP” at the International Stroke Conference, Dallas, Texas – USA. February 7th, 2023.
Dr. Bushra Javed, UNC MS/Neuroimmunology Fellow, presented the poster “Brain leptomeningeal contrast enhancement and cranial nerve enhancement in a pediatric-onset multiple sclerosis patient during fingolimod rebound: a case report” at the 2023 Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum (February 23-25, 2023; San Diego, CA). In addition to Dr. Javed, poster was co-authored by Dr. Loulwah Mukharesh, Clara Zelasky, Stephanie Iyer, Dr. Monica M. Diaz. and mentored by Dr. Irena Dujmovic Basuroski.
James F. Howard, Jr., M.D., FAAN
Howard JF Jr, Reducing the Disease and Treatment Burdens of Myasthenia Gravis with Targeted Therapies, at Cleveland Clinic Department of Neurology Grand Rounds, Cincinnati, OH, March 8, 2023
Tarc C, Boroojerdi B, Leite MI, Genge A, Hussain Y, Kaminski HJ, Mantegazza R, Vu T, Brock M, Vanderkelen M, De la Borderie G, Duda PW, Utsugisawa K, Howard JF Jr, on behalf of the RAISE investigators (Chopra M, Traub RE): Efficacité et sécurité du zilucoplan chez les patients atteints de myasthénie grave généralisée (MGg): résultats de l’étude de phase 3. Poster presented at the 27e Journées de la Société Francophone du Nerf Périphérique (SFNP) 2023, Paris, France; 10–11 March 2023.
Mozaffar T, Mantegazza R, Attarian S, Vissing J, Yoshimura S, Beasley K, Liao S, Pandya S Howard JF Jr: Ravulizumab in Adults with Generalized Myasthenia Gravis: A Post hoc Analysis of the Phase 3 CHAMPION MG Study by Muscle Domain. Poster presented at the 2023 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference, Dallas, TX, 19-22 March 2023.
Behr, M, Li G, Vu T, Bril V, Margania T, Korobko D, Smilowski M, Banaszkiewicz K, Liu L, Steeland S, Noukens J, Van Hoorick B, Podhorna J, Li Y, Utsugisawa K, Wiendl H, De Bleecker JL, Mantegazza R, Howard JF Jr in collaboration with the ADAPTsc Study Group (Chopra M): Pharmacodynamic Noninferiority Study Comparing Subcutaneous Injections of Efgartigimod PH20 With Intravenous Infusions of Efgartigimod: Results of Phase 3 ADAPTsc Study. Poster presented at the 2023 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference, Dallas, TX, 19-22 March 2023.
Gelinas D, Vu T, Bril V, Karam C, Peric S, De Bleecker JL, Murai H, Pasnoor M, Sacca F, Meisel A, T’joen C, Utsugisawa K, Mantegazza R, Howard JF Jr in collaboration with the ADAPT Study Group (Chopra M): Efficacy, Safety, and Tolerability of Efgartigimod in AChR-Ab– Patients With Generalized Myasthenia Gravis: Interim Analysis of ADAPT/ADAPT+ Studies. Poster presented at the 2023 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference, Dallas, TX, 19-22 March 2023.
Ritt E, Bril V, Vu T, Brauer E, Kerstens R, Howard JF Jr in collaboration with the ADAPT Study Group (Chopra M): Efgartigimod Demonstrates Consistent Improvements in Generalized Myasthenia Gravis Across Patient Subgroups, Including Early in Diagnosis. Poster presented at the 2023 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference, Dallas, TX, 19-22 March 2023.
Howard JF Jr, Bril V, Vu T, Peric S, De Bleecker JL, Murai H. Meisel A, Beydoun S, Pasnoor M, T’joen C, Utsugisawa K, Mantegazza R in collaboration with the ADAPT Investigator Study Group (Chopra M): Long-term Safety and Efficacy of Efgartigimod in Patients With Generalized Myasthenia Gravis: Interim Results of the ADAPT+ Study. Poster presented at 26th Congress of the Medical-Scientific Advisory Board of the German Society for Muscle Diseases (DGM); Essen, Germany, 22─24 March 2023.
Behr M, Lünemann JD, Li G, Vu T, Bril V, Margania T, Korobko D, Smilowski M, Liu L, Steeland S, Noukens J. van Hoorick B, Podhorna J, Li Y, Utsugisawa K, Wiendl H, De Bleecker JL, Mantegazza R, Howard JF Jr, for the ADAPT-SC study group (Chopra M): Pharmacodynamic Noninferiority Study Comparing Subcutaneous Efgartigimod PH20 With Intravenous Efgartigimod: Results of Phase 3 ADAPT-SC Study. Poster presented at 26th Congress of the Medical-Scientific Advisory Board of the German Society for Muscle Diseases (DGM); Essen, Germany, 22─24 March 2023.
Winnie Lau, MD gave the opening plenary presentation “Faculty Thriving in Academic Medicine: From Mission Impossible to Mission Accomplished” at the AAMC Council of Faculty and Academic Societies in March.
PGY 3 Resident and rising Chief James Andrews presented his poster“Application of the Yale Adult EEG Background Grading Scale at a Single Center” at ACNS conference. There is a picture of this on social media that you can take.
Clio Rubinos, MD, MSCR
Speaker and Moderator “Balancing the Risk-Benefit Ratio of Anti-Seizure Treatment in Acute Brain Injury” at the American Clinical Neurophysiology Society, Austin, Texas – March 29th, 2023.
Abstracts presented:
Andrews J, LaRoche S, Rubinos C. Application of the Yale Adult EEG background Grading Scale at a Single Center. American Clinical Neurophysiology Society, March 26 – 30th, 2023
Ian Shih presented seminars about new fMRI technologies at the Massachusetts Institute of Technology and the Purdue University; presented MRI-compatible brain stimulation/recording strategies in a Neuromodulation Workshop at the National Institute of Health; and shared his experience in securing federal funding for small business at the NC State CATALYZE Entrepreneurship Workshop.
David Y. Hwang, MD, FAAN, FCCM, FNCS
Dave Hwang, MD, recently presented “Supporting surrogate decision makers in neuroscience ICUs” at UNC’s Comprehensive Cancer Support Program / Palliative Care Grand Rounds.
Dave Hwang, MD, was an invited panelist at the International Stroke Conference in Dallas, TX, for an educational session program entitled, “Who should we save? A multidisciplinary case-based discussion.”
The 75th AAN Annual Meeting – April 22-27 – Boston & Virtual:
- Ana C.G. Felix, MBBCh, FAAN, Vice Chair of the AAN AB Baker Section on Neurology Education, and SOM senior student Faris Almubaslat were invited to present the at the 75th Academy of Neurology Meeting in Boston in April 2023. AAN A.B. Baker Section Spotlight on Engaging Early Learners Through SIGN.
- Chhitij Tiwari (SOM Senior student; Research Advisor: Clio A. Rubinos, MD; Academic Advisor: Ana C.G. Felix, MBBCh, FAAN
- Poster Presentation: Treatment of Refractory Vasospasm after Aneurysmal Subarachnoid Hemorrhage: What else could we do for our patients? A Case Report and Systemic Literature Review.
- Authors: Chhitij Tiwari, Clio A. Rubinos, MD, James Pham Ho, MD, Rizk Alghorazi, Jamie Conklin, Matthew Mauck, MD,PhD, Kassie Lyn McCullagh, MD
- Nathaniel Wooten, MD
- Poster Presentation: A Rare Case of Bilateral Optic Perineuritis, Scleritis and Uveitis in a Pediatric Patient Following Influenza Vaccination.
- Authors: Nathaniel Gray Wooten, MD, Irena Dujmovic Basuroski, MD, PhD, Bushra Javed, MD, Jordan Broman-Fulks, MD, Aliese Sarkissian, MD, and Maja Kostic, MD.
- Faris Almubaslat, MPH (SOM Senior Student)
- Poster Presentation: The prevalence and etiologies of transverse myelitis in Latin America.
- Authors: Faris Almubaslat, MPH, Monica M. Diaz, MD, Matthew Underwood, Carrie Baldwin-SoRelle, Rebecca Carlson, Rocio Aponte Castro, Stacy Torian, and Justina Luz Salvatierra, Jr.
- Cesarina S. Thohan, MD and Fazila Aseem, MD, MPH
- Poster Presentation: Cerebral White Matter Injury in a Neonate with COVID-19 Infection.
- Authors: Cesarina S. Thohan, MD, Casey Olm-Shipman, MD, Fazila Aseem, MPH, Melissa Martinez Johnson, MD, Yueh Lee, Zachary Willis, MD, and Afsaneh Pirzadeh, MD.
- Nikash Shankar (incoming intern class of 2027)
- Poster Presentation: Differences in Stroke Outcomes and experiences between White and Minority Patients and Providers.
- Authors: Nikash Shankar, Mary Carter Denny, MD, and Mykaiya Sumling.
- Laura De Lima Xavier, MD
- Poster Presentation: Self versus Machine: Clinical and ethical implications of the effects of deep brain stimulation on cognition.
- Author: Laura De Lima Xavier, MD
- Bushra Javed, MD
- Nikoloz Karazanashvili, MD and Fazila Aseem, MD, MPH
- Poster Presentation: Resting State fMRI for Neuroprognostication in Traumatic Brain Injury: Clinical Experience of Evaluation for Covert Consciousness and Epileptogenic Networks in Acute Coma.
- Authors: Nikoloz Karazanashvili, MD, Varina Boerwinkle, MD, Tamara Strohm, MD, Fazila Aseem, MPH, Julia Carlson, MD, Olivia Gilbert, MD, and Kirsten Gillette.
- Joshua Nardin, DO –
- Poster Presentation: Description of a Rare Compound Heterozygous Transthyretin Mutation Val30Met/Val122Ile Conferring Early Onset Hereditary Amyloidosis with Severe Features.
- Authors: Joshua Nardin, DO, and Rebecca Traub, MD
- Rizk Alghorazi
- Poster Presentation: EEG Characteristics of Mortality in Patients with Altered Mental Status and Seizures: A Matched Case-Control Study.
- Authors: Rizk Alghorazi, Angela Wabulya, MB ChB, Clio A. Rubinos, MD, Zhu Hongtu, Carolyn Tsai, MD
James F. Howard, Jr., M.D., FAAN
Howard JF Jr, Rational Approaches to the Treatment of Myasthenia Gravis, at the 8th University of South Alabama Annual Neuroscience Symposium, Pensacola Beach FL, April 14-16, 2023.
Pasnoor M, Bril V, Karam C, Peric S, De Bleecker J, Murai H, Meisel A, Beydoun S, Vu T, Ulrichts P, Van Hoorick Be, T’joen C, Utsugisawa K, Verschuuren J, Mantegazza R, Howard JF Jr, in collaboration with the ADAPT Investigator study group (Chopra M): Long-Term Safety, Tolerability, And Efficacy of Efgartigimod in Patients with Generalized Myasthenia Gravis: Concluding Analyses from the ADAPT+ Study. Paper read at the 75th Annual Meeting of the American Academy of Neurology, Boston, MA, 23 April 2023.
Muppidi S, Narayanaswami P, Meisel A, Vu T, Utsugisawa K, Mantegazza R, Beasley Ka, Liao S, Howard JF Jr: Achievement of Improved Post-Intervention Status in Patients with Generalized Myasthenia Gravis Treated with Ravulizumab during the CHAMPION MG Study. Paper read at the 75th Annual Meeting of the American Academy of Neurology, Boston, MA, 23 April 2023.
Brandsema JF, Ginsberg M, Hoshino H, Mimaki M, Nagata S, Rao V, Ruzhansky K, Suresh N, Tiongson E, Yamanouchi H, Frick G, Hicks E, Liao S, Howard JF Jr: A Phase 3, Open-Label, Multicenter Study To Evaluate Eculizumab In Adolescents With Refractory Generalized Myasthenia Gravis. Paper read at the 75th Annual Meeting of the American Academy of Neurology, Boston, MA, 23 April 2023.
Gwathmey K, Broome Catherine, Goebeler M, Murai H, Bata-Csörgo Zs, Newland A, Ulrichts P, Kerstens R, Guptill JT, Agha S, Jiang M, Howard JF Jr: Overview of the Safety Profile from Efgartigimod Clinical Trials in Participants with Diverse IgG-Mediated Autoimmune Diseases. Poster presented at the 75th Annual Meeting of the American Academy of Neurology, Boston, MA, 23 April 2023.
Habib A, Benatar M, Vu T, Meisel A, Attarian S, Katsuno M, Liao S, Beasley K, Howard JF Jr: Ravulizumab for the Treatment of Generalized Myasthenia Gravis: Timing of Response. Poster presented at the 75th Annual Meeting of the American Academy of Neurology, Boston, MA, 23 April 2023.
Howard JF Jr, Rakhade S, Scholz J, Ortiz S, Shang S, Vu T: Study design and methodology of the PREVAIL trial: a phase 3, randomized, double-blind, placebo-controlled study of the safety and efficacy of subcutaneous ALXN1720 in adults with generalized myasthenia gravis. Poster presented at the 75th Annual Meeting of the American Academy of Neurology, Boston, MA, 23 April 2023.
Howard JF Jr, Li G, Vu T, Margania T, Korobko D, Smilowski M, Banaszkiewicz K, Liu L, Steeland S, Noukens J, Van Hoorick B, Podhorna J, Li Y, Utsugisawa K, Sacca F, Wiendl H, De Bleecker JL, Mantegazza R, in collaboration with the ADAPT-SC Investigator Study Group (Chopra M): Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Efgartigimod PH20 in Patients with Generalized Myasthenia Gravis: Interim Results of the ADAPT-SC+ Study. Poster presented at the 75th Annual Meeting of the American Academy of Neurology, Boston, MA, 23 April 2023.
Bril V, Vu T, Brauer E, Kerstens R, Howard JF Jr, in collaboration with the with the ADAPT Investigator Study Group (Chopra M): Efgartigimod Demonstrates Consistent Improvements in Generalized Myasthenia Gravis Patients of Shorter Disease Duration. Poster presented at the 75th Annual Meeting of the American Academy of Neurology, Boston, MA, 23 April 2023.
Li G, Li Y, Vu T, Korobko D, Smilowski M, Liu L, Steeland S, Van Hoorick B, Podhorna J, Casey J, Noukens J, Van Bragt T, Utsugisawa K, Wiendl H, De Bleecker J, Mantegazza R, Howard JF Jr and the ADAPT-SC Investigator Study Group (Chopra M): Dose Selection and Clinical Development of Efgartigimod PH20 Subcutaneous in Patients with Generalized Myasthenia Gravis. Poster presented at the 75th Annual Meeting of the American Academy of Neurology, Boston, MA, 23 April 2023.
Green E, Cutter G, Muppidi S, Juel V, Rodriques E, Korideck H, Howard JF Jr: Myasthenia Gravis Activities of Daily Living (MG-ADL) Response to Eculizumab Treatment in Patients from the Generalized Myasthenia Gravis Registry. Poster resented at the 75th Annual Meeting of the American Academy of Neurology, Boston, MA, 23 April 2023.
Freimer M, Leite I, Genge A, Hussain Y, Kaminski HJ, Mantegazza R, Utsugisawa K, Vu T, Duda PW, Boroojerdi B, Vanderkelen M, Lowcock R, Howard JF Jr: RAISE-XT: An interim analysis of safety and efficacy in an open-label extension study of zilucoplan in patients with myasthenia gravis. Poster presented at the 75th Annual Meeting of the American Academy of Neurology, Boston, MA, 23 April 2023.
Weiss MD, Bresch S, Freimer M, Hewamadduma C, Juntas-Morales R, M. Leite I, Maniaol A, Masuda M, Sivakumar K, Zajda M, Boroojerdi B, Duda PW, de la Borderie G, Howard JF Jr: Subgroup outcomes from RAISE: A randomized, Phase 3 trial of zilucoplan in generalized myasthenia gravis. Poster presented at the 75th Annual Meeting of the American Academy of Neurology, Boston, MA, 23 April 2023.
James F. Howard, Jr., M.D., FAAN
Howard JF Jr, The Role of Single Fiber EMG in the Management of Disorders of Neuromuscular Transmission & Its Utility in Other Diseases. at the 15th Annual Neuroscience Conference (ANC), Bibliotheca Alexandrina, Alexandria Egypt, May 3, 2023.
Howard JF Jr, Update in the Management of Myasthenia Gravis. at the 15th Annual Neuroscience Conference (ANC), Bibliotheca Alexandrina, Alexandria Egypt, May 4, 2023.
Hewamadduma C, Bresch S, Juntas-Morales R, Leite MI, Maniaol A, Zajda M, Boroojerdi B, Duda PW, Guillemette de la Borderie9, de la Borderie G, Howard JF Jr on behalf of the RAISE-XT study team. Poster to be presented at the Annual Meeting of the Association of British Neurologists and the Irish Neurological Association, Belfast, Ireland, 9-12 May 2023.
Leite MI, Genge A, Mantegazza R, Utsugisawa K, Duda PW, Boroojerdi B, Vanderkelen M, de la Borderie G, Howard JF Jr on behalf of the RAISE-XT study team. RAISE-XT: An interim analysis of safety and efficacy in an open-label extension study of zilucoplan in patients with myasthenia gravis. Poster to be presented at the Annual Meeting of the Association of British Neurologists and the Irish Neurological Association, Belfast, Ireland, 9-12 May 2023.
James F. Howard, Jr., M.D., FAAN
Murai H, Masuda M, Genge A, Hussain Y, Kaminski HJ, Leite MI, Mantegazza R, Utsugisawa K, Vu T, Brock M, Boroojerdi B, Vanderkelen M, de la Borderie G, Duda PW, Howard JF Jr on behalf of the RAISE-XT investigators: RAISE-XT (Chopra M): Safety and tolerability of zilucoplan in patients with myasthenia gravis. Poster presented at the 64th Annual Meeting of the Japanese Society of Neurology, Chiba, Tokyo, Japan, 31 May to 3 June 2023.
Masuda M, Uzawa A, Takahashi M, Murai H, Howard JF Jr, Mantegazza R, Steeland S, Van Hoorick B, T’joen C, Utsugisawa K: Long-term Safety and Efficacy of Efgartigimod in Japanese Patients With gMG: ADAPT+ Final Analysis. Poster presented at the 64th Annual Meeting of the Japanese Society of Neurology, Chiba, Tokyo, Japan, 31 May to 3 June, 2023.
Pasnoor M, Bril V, Karam C, Peric S, De Bleecker J, Murai H, Meisel A, Beydoun S, Vu T, Ulrichts P, Van Hoorick Be, T’joen C, Utsugisawa K, Verschuuren J, Mantegazza R, Howard JF Jr, in collaboration with the ADAPT Investigator Study Group (Chopra M): Long-Term Safety, Tolerability, And Efficacy of Efgartigimod in Patients with Generalized Myasthenia Gravis: Concluding Analyses from the ADAPT+ Study. Poster presented at the 2023 Canadian Neurological Sciences Foundation Congress (CNSF), Banff, Alberta, Canada, 6-9 June 2023.
Siddiqi Z, Howard JF Jr, Bril V, Vu T, Karam C, Pasnoor M, Muppidi S, Peric S, Murai H, Ulrichts P, T’joen C, Utsugisawa K, Verschuuren J, Mantegazza R, for the ADAPT Investigator Study Group (Chopra M): Minimal Symptom Expression Following Treatment With Efgartigimod in Participants With Generalized Myasthenia Gravis. Poster presented at the 2023 Canadian Neurological Sciences Foundation Congress (CNSF), Banff, Alberta, Canada, 6-9 June 2023.
Bril V, Behin A, Gwathmey K, Broome C, Goebeler M, Murai H, Bata-Csörgo Z, Newland A, Ulrichts P, Kerstens R, Guptill J, Agha S, Jiang M, Howard JF Jr: Safety Profile From Efgartigimod Clinical Trials in Participants With Diverse IgG-Mediated Autoimmune Diseases. Poster presented at the 2023 Canadian Neurological Sciences Foundation Congress (CNSF), Banff, Alberta, Canada, 6-9 June 2023.
Bril V, Vu T, Karam C, Peric S, De Bleecker J, Murai H, Pasnoor M, Saccà F, Meisel A, T’joen C, Utsugisawa K, Mantegazza R, Howard JF Jr: Efficacy, Safety, and Tolerability of Efgartigimod in AChR-Ab– Patients With Generalized Myasthenia Gravis: Interim Analysis of ADAPT/ADAPT+. Poster presented at the 2023 Canadian Neurological Sciences Foundation Congress (CNSF), Banff, Alberta, Canada, 6-9 June 2023.
Pasnoor M, Bril V, Karam C, Peric S, De Bleecker J, Murai H, Meisel A, Beydoun S, Vu T, Ulrichts P, Van Hoorick Be, T’joen C, Utsugisawa K, Verschuuren J, Mantegazza R, Howard JF Jr, in collaboration with the ADAPT Investigator Study Group (Chopra M): Long-Term Safety, Tolerability, And Efficacy of Efgartigimod in Patients with Generalized Myasthenia Gravis: Concluding Analyses from the ADAPT+ Study. Poster presented at the XXI Congres AL Societăţii de Neurologie din România (SNR), Sinaia, Romania, June 7-9, 2023.
Antozzi C, Freimer M, Leite MI, Genge A, Hussain Y, Mantegazza R, Utsugisawa K, Vu T, Duda PW, Boroojerdi B, Vanderkelen M, Lowcock R, Howard JF Jr, on behalf of the RAISE-XT study investigators (Chopra M): RAISE-XT: An interim analysis of safety and efficacy in an open-label extension study of zilucoplan in patients with myasthenia gravis. Paper read at the XXIII Congresso Nazionale Associazione Italiana di Miologia (AIM), Padova, Italy, 8-10 June 2023.
Habib A, Benatar M, Vu T, Meisel A, Attarian S, Katsuno M, Liao S, Beasley K, Howard JF Jr: Ravulizumab for the Treatment of Generalized Myasthenia Gravis: Timing of Response. Poster presented by Mantegazza R at the the XXIII Congresso Nazionale Associazione Italiana di Miologia (AIM), Padova, Italy, 8-10 June 2023.
Howard JF Jr, Li G, Vu T, Korobko D, Smilowski M, Szczudlik A, Banaszkiewicz K, Lui L, Steeland S, Noukens J, Van Hoorick B, Podhorna J, Li Y, Utsugisawa K, Sacca F, Wiendl H, De Bleecker JL, Mantegazza R: Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Efgartigimod PH20 in Patients with Generalized Myasthenia Gravis: Interim Results of the ADAPT-SC+ Study. Paper read at the XXIII Congresso Nazionale Associazione Italiana di Miologia (AIM), Padova, Italy, 8-10 June 2023, Padova, Italy, 8-10 June 2023.
Mantegazza RE, Habib AA, Benatar M, Vu T, Meisel A, Attarian S, Katsuno M, Liao S, Beasley KN, Howard JF Jr: Ravulizumab for the treatment of generalized myasthenia gravis: timing of response. Poster presented at the XXIII Congresso Nazionale Associazione Italiana di Miologia (AIM), Padova, Italy, 8-10 June 2023, Padova, Italy, 8-10 June 2023.
Suhl J, Conway K, Rasmussen SA, Howard JF Jr, Andrews J, Thomas S, Johnson N, Alese JT, Romitti P, Mathews K, and the MD STARnet: Pain Medication for Individuals with Facioscapulohumeral Muscular Dystrophy in the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet). Poster presented at the 30th Annual FSHD Society International Research Conference, Milan, Italy, 15-16 June 2023.
Pasnoor M, Bril V, Karam C, Peric S, De Bleecker J, Murai H, Meisel A, Beydoun S, Vu T, Rocca F, Ulrichts P, Van Hoorick B, T’joen C, Utsugisawa K, Verschuuren J, Mantegazza R, Howard JF Jr and the ADAPT Investigator Study Group (Chopra M): Long-Term Safety, Tolerability, And Efficacy of Efgartigimod in Patients with Generalized Myasthenia Gravis: Concluding Analyses from the ADAPT+ Study. Paper read at the 34th Hellenic Congress of Neurology, Athens, Greece, 15-18 June 2023.
Gwathmey K, Broome Catherine, Goebeler M, Murai H, Bata-Csörgo Zs, Newland A, Rocca F, Ulrichts P, Kerstens R, Guptill JT, Agha S, Jiang M, Howard JF Jr: Overview of the Safety Profile from Efgartigimod Clinical Trials in Participants with Diverse IgG-Mediated Autoimmune Diseases. Paper read at the 34th Hellenic Congress of Neurology, Athens, Greece, 15-18 June 2023.
Sholzberg M, Gwathmey K, Broome CM, Goebeler M, Murai H, Bata-Csörgo Z, Newland A, Ulrichts P, Kerstens R, Guptill JT, Agha S, Jiang M, Howard JF Jr: Safety Profile of Efgartigimod from Clinical Trials in Participants with Immunoglobulin G-Mediated Autoimmune Diseases. Poster presented at the 31st Congress of the International Society on Thrombosis and Haemostasis (ISTH), Montreal, Canada, 24-28 June 2023.
James F. Howard, Jr., M.D., FAAN
Mantegazza R, Bresch S, Freimer M, Genge A, Hewamadduma C, Leite MI, Maniaol A, Schmidt J, Utsugisawa K, Vu T, Boroojerdi B, Lejdstrom RB, Duda PW, Grimson F, Savic N, Howard JF Jr and the RAISE study team (Chopra M): Response to Zilucoplan in the Phase 3 Randomised RAISE Study in Patients with Generalised Myasthenia Gravis. ePresentation read at the 9th European Academy of Neurology Congress, Budapest, Hungary, 1-4 July 2023.
Leite MI, Bresch S, Freimer M, Genge A, Hewamadduma C, Hussain Y, Maniaol A, Mantegazza R, Smilowski M, Utsugisawa K, Vu T, Duda PW, Boroojerdi B, Vanderkelen M, de la Borderie G, Bloemers J, Howard JF Jr on behalf of the RAISE-XT study team (Chopra M): Long-term safety, efficacy, self-injection satisfaction with zilucoplan in myasthenia gravis: An Interim analysis of RAISE-XT. ePoster presented at the 9th European Academy of Neurology Congress, Budapest, Hungary, 1-4 July 2023.
Rózsa C, Sacca F, De Bleecker JL, Verschuuren J, Hoffman S, Vu T, Bril V, Murai H, Brauer E, Kerstens R, Steeland S, Ulrichts P, Goyal N, Vissing J, Mantegazza R, Howard JF Jr and the ADAPT Investigator Study Group (Chopra M): Efgartigimod Demonstrates Consistent Improvements in Patients With gMG Regardless of Prior Treatment Failures. ePoster (#EPO-388) presented at the 9th European Academy of Neurology Congress, Budapest, Hungary, 1-4 July 2023.
Meisel A, De Bleecker JL, Verschuuren J, Bril V, Vu T, Karam C, Peric S, Murai H, Beydoun S, Pasnoor M, Steeland S, Van Hoorick B, T’joen C, Utsugisawa K, Mantegazza R, Howard JF Jr and the ADAPT Investigator Study Group (Chopra M): Long-term Safety, Tolerability and Efficacy of Efgartigimod in Patients with GMG: Final Analysis from the ADAPT+ Study. ePresentation given at the 9th European Academy of Neurology Congress, Budapest, Hungary, 1-4 July 2023.
Hoffmann S, Meisel A, Attarian S, De Bleecker JL, Vissing J, Kerstens R, Brauer E, Utsugisawa K, Goyal N, Li Y, Peric S, Howard JF Jr, Saccà F, and the ADAPT Investigator Study Group (Chopra M): Efgartigimod Demonstrates Consistent Magnitude of Response Across Subgroups of Patients With GMG. ePoster (#EPO-054) presented at the 9th European Academy of Neurology Congress, Budapest, Hungary, 1-4 July 2023.
Benin A, Gwathmey K, Broome Catherine, Goebeler M, Murai H, Bata-Csörgo Zs, Newland A, Ulrichts P, Kerstens R, Guptill JT, Agha S, Jiang M, Howard JF Jr: Safety Profile of Efgartigimod Clinical Trials in Participants with Diverse IgG-Mediated Autoimmune Diseases. Paper to be read at the 9th European Academy of Neurology Congress, Budapest, Hungary, 1-4 July 2023.
Vissing J, Mozaffar T, Mantegazza R, Attarian S. Yoshimura S. Beasley KN, Liao S. Pandya S, Howard JF Jr: Ravulizumab in adults with generalised myasthenia gravis: Post hoc analysis of MG-ADL item score change in CHAMPION MG. Paper read at the 9th European Academy of Neurology Congress, Budapest, Hungary, 1-4 July 2023.